Momenta Pharmaceuticals
Why Robinhood?
You can watch MNTA and buy or sell other stocks, ETFs, and their options commission-free!About MNTA
Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection.
MNTA Key Statistics
Stock Snapshot
With a market cap of 6.24B, Momenta Pharmaceuticals(MNTA) trades at $52.48. The stock has a price-to-earnings ratio of -24.70.
Momenta Pharmaceuticals(MNTA) stock opened on 2026-05-01 at —. The price climbed to — and dipped to —.
Momenta Pharmaceuticals(MNTA) shares are trading with a volume of 0, against a daily average of 2.68M.
During the past year, Momenta Pharmaceuticals(MNTA) stock moved between $12.58 at its lowest and $52.53 at its peak.
During the past year, Momenta Pharmaceuticals(MNTA) stock moved between $12.58 at its lowest and $52.53 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.